We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Outpaces Overseas Counterparts in Speeding Drug Approvals, Study Finds
U.S. FDA Outpaces Overseas Counterparts in Speeding Drug Approvals, Study Finds
The U.S. Food and Drug Administration has been quicker to approve new active substances over the last decade than both its European and Japanese counterparts, a recent study finds.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor